1Ford AC,Suares NC.Effect of laxatives and pharmacological therapies in chronic idiopathic constipation:systematic review and meta-analysis[J].Gut,2011,60(2):209-218.
2Tack J,Müller-Lissner S,Stanghellini V,et al.Diagnosis and treatment of chronic constipation-a European perspective[J].Neurogastroenterol Mot il,2011,23 (8):697-710.
3Bouhnik Y,Neut C,Raskine L,et al.Prospective,randomized,parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation[J].Aliment Pharmacol Ther,2004,19 (8):889-899.
4American College of Gastroenterology Chronic Constipation Task Force.An evidence-based approach to the management of chronic constipation in North America[J].Am J Gastroenterol,2005,100 Suppl 1:S1-4.
5Kamm MA,Mueller-Lissner S,Wald A,et al.Oral bisacodyl is effective and well-tolerated in patients with chronic constipation[J].Clin Gastroenterol Hepatol,2011,9(7):577-583.
7Lindberg G,Hamid SS,Malfertheiner P,et al.World Gastroenterology Organisation global guideline:constipation--a global perspective[J].J Clin Gastroenterol,2011,45 (6):483-487.
8Ke M,Zou D,Yuan Y,et al.Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region:a randomized,double-blind,placebo-controlled study[J]Neurogastroenterol Motil,2012,24(11):999-e541.
9Camilleri M,Beyens G,Kerstens R,et al.Safety assessment of prucalopride in elderly patients with constipation:a double-blind,placebo-controlled study[J].Neurogastroenterol Motil,2009,21(12):1256-e1 17.
10Barish CF,Drossman D,Johanson JF,et al.Efficacy and safety of lubiprostone in patients with chronic constipation[J].Dig Dis Sci,2010,55(4):1090-1097.
